AsiaGen Corporation was founded in March 2000. Its strategy is to explore the core technology of “Liquid Array” and has successfully established RAPID Array® (magnetic beads-based), Mobile Array® (Luminex®-based) and Hybrid Strip™ Technologies. By using these proprietary technologies, AsiaGen is developing, manufacturing and marketing a series of molecular probing kits for a variety of infectious diseases and cancers based on genomic study.

AsiaGen also develop and promote DNA-labeling chemicals for molecular diagnostics both in local and oversea markets. Not only proficient in R&D, products manufacturing and marketing, the team members of AsiaGen are also capable of pursuing and managing the business after their completion of professional training and working experiences in the United States. AsiaGen Corporation has been stationed in Southern Taiwan Science Park (STSP) since 2001. In STSP campus, AsiaGen operates one certified GMP facility and two BL-2 level laboratories for studying microbiology, molecular biology and chemistry.

In June of 2014, AsiaGen has expanded its territory into New Taipei City, Northern Taiwan. In the well-established MIT Int’l Technology Park, Zhonghe Dist., AsiaGen built up an advanced BSL3 Lab and one more GMP facility to fulfill the goal of international training and service center for the control of regional and global infectious diseases.

AsiaGen cooperates very closely with the CDC of MOH, Taiwan and expected to turn into the “Global home of in vitro molecular diagnostics” and provides products with high quality and reward to strengthen healthcare of human beings.